Bill Rastetter, Jeff Huber, Ken Drazan

Grail, a company aiming to develop a blood test for early cancer detection, has named Bill Rastetter, current chair of the company's board of directors, as its new CEO. Founding CEO Jeff Huber is now vice chairman of the board of directors, and Ken Drazan has been promoted from chief business officer to president.